Banking for the future together - CDL Laboratories partners with Insception
Biosciences

Signing of Strategic partnership will provide more options
For Quebec families and potentially save lives.

MONTREAL, Sept. 21 /CNW Telbec/ - CDL Laboratories announced today their partnership with Insception Cord Blood Program.  Insception is the largest and most experienced family cord blood program in Canada. Inception has the greatest number of successful transplants, more than all the other Canadian family banks combined. 

"This is a great asset for CDL Laboratories", said President, Laurent Amram.  "Working with many hospitals across Quebec and hundreds of physicians enables us to offer their patients the option to  store their umbilical cord blood at the leading center in research, storage and transfusion of stem cells in Canada".

Medical experts and researchers have been discussing the medical benefits of umbilical cord blood for years.  Umbilical cord blood saves lives; it has been used in the treatment of more than 75 diseases including lymphoma, leukemia and heart disease.  Until recently, cord blood was primarily used for children and young adults.   New research is now showing with that with multiple cord blood units you can now save adults from life threatening cancers. Cord Blood Stem cell use for Cellular Therapy and Regenerative medicine applications for many diseases such as Cerebral Palsy, Diabetes Type1, Alzheimer's and ALS is showing very promising results.

"This partnership brings two well respected companies with complementary areas of expertise together", said Richard Lockie, Chairman and CEO, Insception Biosciences "Our goal is increase awareness of the benefits of banking your Child's umbilical cord blood stem cells and provide local support and education for both Health Care Providers and expectant parents of Quebec".

Established in 1993, CDL Laboratories Inc. ,and its teams of over 100 employees, has developed a testing menu of over 2000 diagnostic laboratory analyses. CDL is licensed and accredited by the Quebec Ministry of Health and Social Services, C.A.P. (College of American Pathologists), CLIA (Clinical Laboratory Improvements Amendments), and the New York State Department of Health. CDL complies with GLP (Good Laboratory Practice) standards. CDL provides quality service to over 1000 medical clinics, physicians' offices and pharmacological companies throughout the province of Quebec.
For more information visit www.cdllabs.com

Insception is the largest cord blood program in Canada, with over 33,000 cord blood units banked. By continuing to partner with leading Canadian medical facilities such as Toronto's Mount Sinai Hospital, the Insception Cord Blood Program is able to provide every family with the opportunity to collect and store their baby's valuable cord blood, while the company's Biosciences division focuses on developing new and improved applications for stem cells. For more information, log onto www.insception.com

For further information:

Media Contact: Stephanie Suissa
[phone] ext 235
[email protected]